Track market-moving stories before they get noisy

, /PRNewswire/ -- AGNC Investment Corp. ("AGNC" or the "Company") (Nasdaq: AGNC) today announced financial results for the quarter ended June 30, 2026. 

SECOND QUARTER 2026 FINANCIAL HIGHLIGHTS

$0.52 comprehensive income per common share, comprised of: $0.52 net income per common share $(0.01) other comprehensive loss ("OCI") per common share on investments marked-to-market through OCI $0.40 net spread and dollar roll income per common share1 Excludes less than $(0.01) per common share of estimated "catch-up" premium amortization cost due to change in projected constant prepayment rate ("CPR") estimates $8.58 tangible net book value per common share as of June 30, 2026 Increased $0.20 per common share, or 2.4%, from $8.38 per common share as of March 31, 2026 $0.36 dividends declared per common share for the second quarter  6.7% economic return on tangible common equity for the quarter Comprised of $0.36 dividends per common share and $0.20 increase in tangible net book value per common share OTHER SECOND QUARTER HIGHLIGHTS

$97.2 billion investment portfolio as of June 30, 2026, comprised of: $86.8 billion Agency mortgage-backed securities ("Agency MBS") $9.7 billion net forward purchases/(sales) of Agency MBS in the "to-be-announced" market ("TBA securities") $0.7 billion credit risk transfer ("CRT") and non-Agency securities and other mortgage credit investments 7.4x tangible net book value "at risk" leverage as of June 30, 2026 7.4x average tangible net book value "at risk" leverage for the quarter Unencumbered cash and Agency MBS totaled $7.5 billion as of June 30, 2026  Excludes unencumbered CRT and non-Agency securities Represents 62% of the Company's tangible equity as of June 30, 2026 8.6% average projected portfolio life CPR as of June 30, 2026 13.0% actual portfolio CPR for the quarter  2.00% annualized net interest spread for the quarter2  Issued 16.2 million shares of common equity through At-the-Market ("ATM") Offerings for net proceeds of $167 million ___________

Represents a non-GAAP measure. Please refer to the Reconciliation of GAAP Comprehensive Income (Loss) to Net Spread and Dollar Roll Income and Use of Non-GAAP Financial Information included in this release for additional information. Please refer to Net Interest Spread Components by Funding Source included in this release for additional information regarding the Company's annualized net interest spread. MANAGEMENT REMARKS
"The investment environment in the second quarter continued to be challenging, as escalating rhetoric and hostilities between the United States and Iran largely dictated financial market performance," said Peter Federico, the Company's President, Chief Executive Officer and Chief Investment Officer. "Elevated energy prices and supply chain disruptions were the dominant macroeconomic concerns, particularly in April and May when maritime traffic through the Strait of Hormuz was severely constrained. These concerns caused Treasury yields to increase, the yield curve to flatten, and the market's monetary policy expectations to pivot from rate cuts to rate hikes.

"Despite the volatile macroeconomic backdrop, AGNC delivered a strong economic return of 6.7% for the second quarter. Elevated mortgage rates caused a reduction in projected Agency MBS supply, while demand remained strong, creating a positive technical backdrop that supported Agency MBS performance and drove spreads to benchmark rates tighter. Although mortgage spreads have declined from recent peak levels, they remain elevated by historical standards. Agency MBS also offer compelling value relative to other fixed income alternatives, particularly corporate bonds, which are at or near historically tight spreads to U.S. Treasuries despite record issuance and rising credit concerns. Together, these favorable dynamics should be supportive of Agency MBS performance over the near to intermediate term and position AGNC to continue to deliver strong risk-adjusted returns for our stockholders."

"AGNC's 6.7% economic return on tangible common equity in the second quarter was comprised of $0.36 of dividends per common share and a $0.20 increase in tangible net book value per common share," said Bernice Bell, the Company's Executive Vice President and Chief Financial Officer. "Additionally, AGNC generated a 12.3% unannualized total stock return in the second quarter, with dividends reinvested, despite the significant volatility experienced by financial markets. AGNC's net spread and dollar roll income per common share was $0.40 for the second quarter, a modest decrease of $0.02 per common share from the prior quarter. Finally, AGNC concluded the second quarter with tangible 'at risk' leverage of 7.4x and a substantial liquidity position of $7.5 billion of unencumbered cash and Agency MBS, representing 62% of our tangible equity at quarter end."

TANGIBLE NET BOOK VALUE PER COMMON SHARE
As of June 30, 2026, the Company's tangible net book value per common share was $8.58 per share, an increase of 2.4% for the quarter compared to $8.38 per share as of March 31, 2026. The Company's tangible net book value per common share excludes $526 million, or $0.45 and $0.46 per share, of goodwill as of June 30 and March 31, 2026, respectively.

INVESTMENT PORTFOLIO
As of June 30, 2026, the Company's investment portfolio totaled $97.2 billion, comprised of:

$96.5 billion of Agency MBS and TBA securities, including: $92.1 billion of fixed-rate securities, comprised of: $82.1 billion 30-year MBS, $9.5 billion 30-year TBA securities, net, and $0.5 billion 15 and 20-year MBS and TBA securities; and $4.5 billion of collateralized mortgage obligations ("CMOs"), adjustable-rate and other Agency securities; and $0.7 billion of CRT and non-Agency securities and other mortgage credit investments. As of June 30, 2026, 30-year fixed-rate Agency MBS and TBA securities represented 94% of the Company's investment portfolio, unchanged from March 31, 2026.

As of June 30, 2026, the Company's fixed-rate Agency MBS and TBA securities' weighted average coupon was 5.04%, compared to 4.95% as of March 31, 2026, comprised of the following weighted average coupons:

5.05% for 30-year fixed-rate securities; 4.82% for 15-year fixed-rate securities; and 3.74% for 20-year fixed-rate securities. The Company accounts for TBA securities and other forward settling securities as derivative instruments and recognizes TBA dollar roll income in other gain (loss), net on the Company's financial statements. As of June 30, 2026, such positions had a fair value of $9.7 billion and a GAAP net carrying value of $52 million reported in derivative assets/(liabilities) on the Company's balance sheet, compared to $9.5 billion and $(194) million, respectively, as of March 31, 2026.

CONSTANT PREPAYMENT RATES
The Company's weighted average projected CPR for the remaining life of its Agency securities held as of June 30, 2026 decreased to 8.6% from 10.3% as of March 31, 2026. The Company's weighted average actual CPR for the second quarter was 13.0%, compared to 13.2% for the prior quarter.

The weighted average cost basis of the Company's investment portfolio was 100.7% of par value as of June 30, 2026. The Company's investment portfolio generated net premium amortization cost of $(47) million, or $(0.04) per common share, for the second quarter, which includes a "catch-up" premium amortization cost of $(5) million, or less than $(0.01) per common share, due to changes in the Company's CPR projections for certain securities acquired prior to the second quarter. This compares to net premium amortization cost for the prior quarter of $(52) million, or $(0.05) per common share, including a "catch-up" premium amortization benefit of $5 million, or less than $0.01 per common share. 

ASSET YIELDS, COST OF FUNDS AND NET INTEREST RATE SPREAD
The Company's average asset yield on its investment portfolio, excluding the TBA position, was 4.87% for the second quarter, compared to 4.95% for the prior quarter. Excluding "catch-up" premium amortization, the Company's average asset yield was 4.89% for the second quarter, compared to 4.93% for the prior quarter. Including the TBA position and excluding "catch-up" premium amortization, the Company's average asset yield for the second quarter was 4.89%, compared to 4.98% for the prior quarter.

For the second quarter, the weighted average interest rate on the Company's repurchase agreements was 3.74%, compared to 3.79% for the prior quarter. For the second quarter, the Company's TBA position had an implied financing cost of 3.46%, compared to 3.45% for the prior quarter. Inclusive of interest rate swaps, the Company's combined weighted average cost of funds for the second quarter was 2.89%, compared to 2.92% for the prior quarter.

The Company's annualized net interest spread, including the TBA position and interest rate swaps and excluding "catch-up" premium amortization, for the second quarter was 2.00%, compared to 2.06% for the prior quarter.

NET SPREAD AND DOLLAR ROLL INCOME
The Company recognized net spread and dollar roll income (a non-GAAP financial measure) for the second quarter of $0.40 per common share, compared to $0.42 per common share for the prior quarter. Net spread and dollar roll income excludes less than $(0.01) and less than $0.01 per common share of estimated "catch-up" premium amortization (cost) / benefit for the second quarter and prior quarter, respectively.

The Company's cost of funds, net interest rate spread and net spread and dollar income excludes the impact of the Company's U.S. Treasury hedges, option-based hedges, and other supplemental interest rate hedges. For additional information regarding the Company's U.S. Treasury hedges, please refer to the schedule of Key Statistics included in this release.

A reconciliation of the Company's total comprehensive income (loss) to net spread and dollar roll income and additional information regarding the Company's use of non-GAAP measures are included later in this release. 

LEVERAGE
As of June 30, 2026, $79.5 billion of repurchase agreements and $9.7 billion of net TBA dollar roll positions (at cost) were used to fund the Company's investment portfolio. The remainder, or approximately $10.3 billion, of the Company's repurchase agreements was used to fund short-term purchases of U.S. Treasury securities ("U.S. Treasury Repo") and is not included in the Company's leverage measurements. Inclusive of its net TBA position and net payable/(receivable) for unsettled investment securities, the Company's tangible net book value "at risk" leverage ratio was 7.4x as of June 30, 2026, unchanged from the prior quarter. The Company's average "at risk" leverage ratio for the second quarter was 7.4x tangible net book value, also unchanged from the prior quarter.

As of June 30, 2026, the Company's repurchase agreements used to fund its investment portfolio ("Investment Securities Repo") had a weighted average interest rate of 3.75%, compared to 3.77% as of March 31, 2026, and a weighted average remaining maturity of 13 days, compared to 20 days as of March 31, 2026. As of June 30, 2026, $42.4 billion, or 53%, of the Company's Investment Securities Repo was funded through the Company's captive broker-dealer subsidiary, Bethesda Securities, LLC. 

HEDGING ACTIVITIES
As of June 30, 2026, interest rate swaps, U.S. Treasury positions, option-based hedges (swaptions), and other interest rate hedges equaled 73% of the Company's outstanding balance of Investment Securities Repo, net TBA position, and other debt (collectively, "funding liabilities"), compared to 75% as of March 31, 2026. Excluding option-based hedges, the Company's hedge portfolio covered 82% of its funding liabilities as of June 30, 2026, compared to 83% as of March 31, 2026.

As of June 30, 2026, the Company's pay fixed interest rate swap position totaled $73.8 billion in notional amount, with an average fixed pay rate of 2.76%, an average floating receive rate of 3.68% and an average maturity of 4.0 years, compared to $76.5 billion, 2.67%, 3.68% and 4.1 years, respectively, as of March 31, 2026.

As of June 30, 2026, the Company had a net short U.S. Treasury position of $2.1 billion, receiver swaptions of $7.8 billion outstanding and a two-year swap equivalent long SOFR futures position of $2.6 billion outstanding, compared to a $5.4 billion net long U.S. Treasury position and net receiver swaptions of $7.0 billion as of March 31, 2026.

OTHER GAIN (LOSS), NET
For the second quarter, the Company recorded a net gain of $379 million in other gain (loss), net, or $0.33 per common share, compared to a net loss of $(433) million, or $(0.39) per common share, for the prior quarter. Other gain (loss), net for the second quarter was comprised of:

$(16) million of net realized losses on sales of investment securities; $(90) million of net unrealized losses on investment securities measured at fair value through net income; $179 million of interest rate swap periodic income; $461 million of net gains on interest rate swaps; $(15) million of net losses on interest rate swaptions; $(4) million of net losses on SOFR futures; $(102) million of net losses on U.S. Treasury positions; $44 million of TBA dollar roll income; $(80) million of net mark-to-market losses on TBA securities; and $3 million of other interest income (expense), net; and $(1) million of other miscellaneous losses. OTHER COMPREHENSIVE LOSS
During the second quarter, the Company recorded other comprehensive income (loss) of $(7) million, or $(0.01) per common share, consisting of net unrealized losses on its Agency securities recognized through OCI, compared to $(8) million, or $(0.01) per common share, in the prior quarter.

COMMON STOCK DIVIDENDS
During the second quarter, the Company declared dividends of $0.12 per share to common stockholders of record as of April 30, May 29, and June 30, 2026, totaling $0.36 per share for the quarter. Since its May 2008 initial public offering through the second quarter of 2026, the Company has declared a total of $16.3 billion in common stock dividends, or $50.80 per common share.

FINANCIAL STATEMENTS, OPERATING PERFORMANCE AND PORTFOLIO STATISTICS
The following measures of operating performance include net spread and dollar roll income; economic interest income; economic interest expense; and the related per common share measures and financial metrics derived from such information, which are non-GAAP financial measures. Please refer to "Use of Non-GAAP Financial Information" later in this release for further discussion of non-GAAP measures.

AGNC INVESTMENT CORP.

CONSOLIDATED BALANCE SHEETS

(in millions, except per share data)

June 30,
2026

March 31,
2026

December 31,
2025

September 30,
2025

June 30,
2025

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Assets:

Agency securities, at fair value (including pledged securities of $80,761, $77,364, $74,149, $68,821
and $67,375, respectively)

$                    86,784

$                    84,447

$                    81,003

$                    76,198

$                    73,232

Agency securities transferred to consolidated variable interest entities, at fair value (pledged
securities)

—

—

85

88

91

Credit risk transfer securities, at fair value (including pledged securities of $525, $545, $558, $554 and
$558, respectively)

573

593

606

609

613

Non-Agency securities, at fair value, and other mortgage credit investments (including pledged
securities of $8, $8, $13, $15 and $30, respectively)

94

93

95

97

109

U.S. Treasury securities, at fair value (including pledged securities of $11,295, $12,313, $13,056, 
$5,431 and $3,554, respectively)

12,325

12,582

13,477

5,927

3,565

Cash and cash equivalents

457

493

450

450

656

Restricted cash

1,329

1,864

1,292

1,461

1,216

Derivative assets, at fair value

260

178

169

145

155

Receivable for investment securities sold (including pledged securities of $201, $0, $149, $1,340 and
$0, respectively)

401

—

152

1,502

—

Receivable under reverse repurchase agreements

18,433

17,644

16,615

21,399

21,362

Goodwill

526

526

526

526

526

Other assets (including pledged securities of $0, $0, $0, $74 and $0, respectively)

578

477

607

567

496

Total assets

$                  121,760

$                  118,897

$                  115,077

$                  108,969

$                  102,021

Liabilities:

Repurchase agreements

$                    89,808

$                    87,616

$                    85,286

$                    74,152

$                    69,153

Debt of consolidated variable interest entities, at fair value

—

—

56

58

60

Payable for investment securities purchased

312

933

193

1,225

392

Derivative liabilities, at fair value

137

440

6

87

106

Dividends payable

184

182

182

170

164

Obligation to return securities borrowed under reverse repurchase agreements, at fair value

18,150

17,032

16,452

20,802

21,305

Accounts payable and other liabilities

626

513

509

1,031

494

Total liabilities

109,217

106,716

102,684

97,525

91,674

Stockholders' equity:

Preferred Stock - aggregate liquidation preference of $2,033, $2,033, $2,033, $2,033 and $1,688,
respectively

1,968

1,968

1,968

1,968

1,634

Common stock - $0.01 par value; 1,164.2, 1,147.8, 1,107.6, 1,072.7 and 1,041.7 shares issued and
outstanding, respectively

12

11

11

11

10

Additional paid-in capital

19,830

19,656

19,261

18,892

18,575

Retained deficit

(8,929)

(9,123)

(8,524)

(9,038)

(9,422)

Accumulated other comprehensive loss

(338)

(331)

(323)

(389)

(450)

Total stockholders' equity

12,543

12,181

12,393

11,444

10,347

Total liabilities and stockholders' equity

$                  121,760

$                  118,897

$                  115,077

$                  108,969

$                  102,021

Tangible net book value per common share 1

$                        8.58

$                        8.38

$                        8.88

$                        8.28

$                        7.81

AGNC INVESTMENT CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

(unaudited)

Three Months Ended

June 30,
2026

March 31,
2026

December 31,
2025

September 30,
2025

June 30,
2025

Interest income:

Interest income

$                      1,014

$                      1,050

$                         944

$                         903

$                         830

Interest expense

709

731

738

755

668

Net interest income

305

319

206

148

162

Other gain (loss), net:

Realized (loss) gain on sale of investment securities, net

(16)

74

(26)

(81)

(177)

Unrealized (loss) gain on investment securities measured at fair value through net income, net

(90)

(889)

475

805

270

Gain (loss) on derivative instruments and other investments, net

485

382

340

(36)

(367)

Total other gain (loss), net

379

(433)

789

688

(274)

Expenses:

Compensation and benefits

19

23

30

20

18

Other operating expense

11

11

11

10

10

Total operating expense

30

34

41

30

28

Net income (loss)

654

(148)

954

806

(140)

Dividend on preferred stock

44

44

46

42

38

Net income (loss) available (attributable) to common stockholders

$                         610

$                       (192)

$                         908

$                         764

$                       (178)

Net income (loss)

$                         654

$                       (148)

$                         954

$                         806

$                       (140)

Unrealized (loss) gain on investment securities measured at fair value through other comprehensive
income (loss), net

(7)

(8)

66

61

48

Comprehensive income (loss)

647

(156)

1,020

867

(92)

Dividend on preferred stock

44

44

46

42

38

Comprehensive income (loss) available (attributable) to common stockholders

$                         603

$                       (200)

$                         974

$                         825

$                       (130)

Weighted average number of common shares outstanding - basic

1,157.6

1,122.6

1,089.3

1,053.0

1,017.3

Weighted average number of common shares outstanding - diluted

1,162.0

1,122.6

1094.6

1056.6

1017.3

Net income (loss) per common share - basic

$                        0.53

$                      (0.17)

$                        0.83

$                        0.73

$                      (0.17)

Net income (loss) per common share - diluted

$                        0.52

$                      (0.17)

$                        0.83

$                        0.72

$                      (0.17)

Comprehensive income (loss) per common share - basic

$                        0.52

$                      (0.18)

$                        0.89

$                        0.78

$                      (0.13)

Comprehensive income (loss) per common share - diluted

$                        0.52

$                      (0.18)

$                        0.89

$                        0.78

$                      (0.13)

Dividends declared per common share

$                        0.36

$                        0.36

$                        0.36

$                        0.36

$                        0.36

AGNC INVESTMENT CORP.

RECONCILIATION OF GAAP COMPREHENSIVE INCOME (LOSS) TO NET SPREAD AND DOLLAR ROLL INCOME (NON-GAAP MEASURE) 2

(in millions, except per share data)

(unaudited)

Three Months Ended

June 30,
2026

March 31,
2026

December 31,
2025

September 30,
2025

June 30,
2025

Comprehensive income (loss) available (attributable) to common stockholders

$                         603

$                       (200)

$                         974

$                         825

$                       (130)

Adjustments to exclude realized and unrealized (gains) losses reported through net income:

Realized (gain) loss on sale of investment securities, net

16

(74)

26

81

177

Unrealized (gain) loss on investment securities measured at fair value through net income, net

90

889

(475)

(805)

(270)

(Gain) loss on derivative instruments and other securities, net

(485)

(382)

(340)

36

367

Adjustment to exclude unrealized (gain) loss reported through other comprehensive income:

Unrealized (gain) loss on available-for-sale securities measure at fair value through other
comprehensive income, net

7

8

(66)

(61)

(48)

Other adjustments:

Estimated "catch up" premium amortization cost (benefit) due to change in CPR forecast 3

5

(5)

7

14

(11)

TBA dollar roll income 4,5

44

51

27

23

24

Interest rate swap periodic income, net 4,6

179

182

217

245

282

Other interest income (expense), net 4,7

3

6

9

7

(3)

Net spread and dollar roll income available to common stockholders

$                         462

$                         475

$                         379

$                         365

$                         388

Weighted average number of common shares outstanding - basic

1,157.6

1,122.6

1,089.3

1,053.0

1,017.3

Weighted average number of common shares outstanding - diluted

1,162.0

1,127.3

1,094.6

1,056.6

1,019.6

Net spread and dollar roll income per common share - basic

$                        0.40

$                        0.42

$                        0.35

$                        0.35

$                        0.38

Net spread and dollar roll income per common share - diluted

$                        0.40

$                        0.42

$                        0.35

$                        0.35

$                        0.38

AGNC INVESTMENT CORP.

NET INTEREST SPREAD COMPONENTS BY FUNDING SOURCE 2

(in millions, except per share data)

(unaudited)

Three Months Ended

June 30,
2026

March 31,
2026

December 31,
2025

September 30,
2025

June 30,
2025

Adjusted net interest and dollar roll income:

Economic interest income:

Investment securities - GAAP interest income 8

$                      1,014

$                      1,050

$                         944

$                         903

$                         830

Estimated "catch-up" premium amortization cost (benefit) due to change in CPR forecast 3

5

(5)

7

14

(11)

TBA dollar roll income - implied interest income 4,9

155

140

169

135

154

Economic interest income

1,174

1,185

1,120

1,052

973

Economic interest expense:

Repurchase agreements and other debt - GAAP interest expense

(709)

(731)

(738)

(755)

(668)

TBA dollar roll income - implied interest expense 4,10

(111)

(89)

(142)

(112)

(130)

Interest rate swap periodic income, net 4,6

179

182

217

245

282

Economic interest expense

(641)

(638)

(663)

(622)

(516)

Other interest and dividend income 3

—

—

—

—

—

Adjusted net interest and dollar roll income

$                         533

$                         547

$                         457

$                         430

$                         457

Net interest spread:

Average asset yield:

Investment securities - average asset yield

4.87 %

4.95 %

4.87 %

4.83 %

4.89 %

Estimated "catch-up" premium amortization cost (benefit) due to change in CPR forecast

0.02 %

(0.02) %

0.03 %

0.08 %

(0.06) %

Investment securities average asset yield, excluding "catch-up" premium amortization

4.89 %

4.93 %

4.90 %

4.91 %

4.83 %

TBA securities - average implied asset yield 9

4.87 %

5.42 %

4.91 %

5.31 %

5.14 %

Average asset yield 11

4.89 %

4.98 %

4.91 %

4.95 %

4.87 %

Average total cost of funds:

Repurchase agreements and other debt - average funding cost

3.74 %

3.79 %

4.13 %

4.43 %

4.44 %

TBA securities - average implied funding cost 10

3.46 %

3.45 %

4.03 %

4.31 %

4.29 %

Average cost of funds, before interest rate swap periodic income, net 11

3.70 %

3.75 %

4.11 %

4.42 %

4.42 %

Interest rate swap periodic income, net 12

(0.81) %

(0.83) %

(1.01) %

(1.25) %

(1.56) %

Average total cost of funds 13

2.89 %

2.92 %

3.10 %

3.17 %

2.86 %

Average net interest spread

2.00 %

2.06 %

1.81 %

1.78 %

2.01 %

AGNC INVESTMENT CORP.

KEY STATISTICS*

(in millions, except per share data)

(unaudited)

Three Months Ended

Key Balance Sheet Statistics:

June 30,
2026

March 31,
2026

December 31,
2025

September 30,
2025

June 30,
2025

Investment securities: 8

Fixed-rate Agency MBS, at fair value - as of period end

$                    82,334

$                    80,466

$                    77,483

$                    73,283

$                    71,104

Other Agency MBS, at fair value - as of period end

$                      4,450

$                      3,981

$                      3,605

$                      3,003

$                      2,219

Credit risk transfer securities, at fair value - as of period end

$                         573

$                         593

$                         606

$                         609

$                         613

Non-Agency MBS, at fair value - as of period end 14

$                           24

$                           24

$                           25

$                           28

$                           43

Total investment securities, at fair value - as of period end

$                    87,381

$                    85,064

$                    81,719

$                    76,923

$                    73,979

Total investment securities, at cost - as of period end

$                    88,471

$                    86,058

$                    81,817

$                    77,563

$                    75,484

Total investment securities, at par - as of period end

$                    87,896

$                    84,847

$                    80,830

$                    76,625

$                    74,572

Average investment securities, at cost

$                    83,366

$                    84,814

$                    77,562

$                    74,783

$                    67,887

Average investment securities, at par

$                    82,557

$                    83,659

$                    76,647

$                    73,836

$                    66,876

TBA securities: 15

Net TBA portfolio - as of period end, at fair value

$                      9,728

$                      9,548

$                    12,988

$                    13,841

$                      8,263

Net TBA portfolio - as of period end, at cost

$                      9,676

$                      9,742

$                    12,917

$                    13,805

$                      8,162

Net TBA portfolio - as of period end, carrying value

$                           52

$                       (194)

$                           71

$                           36

$                         101

Average net TBA portfolio, at cost

$                    12,729

$                    10,343

$                    13,764

$                    10,163

$                    11,996

Average repurchase agreements and other debt 16

$                    75,070

$                    77,120

$                    69,943

$                    66,654

$                    59,469

Average stockholders' equity 17

$                    12,447

$                    12,405

$                    11,828

$                    10,732

$                    10,118

Tangible net book value per common share 1

$                        8.58

$                        8.38

$                        8.88

$                        8.28

$                        7.81

Tangible net book value "at risk" leverage - average 18

7.4 :1

7.4 :1

7.4 :1

7.5 :1

7.5 :1

Tangible net book value "at risk" leverage - as of period end 19

7.4 :1

7.4 :1

7.2 :1

7.6 :1

7.6 :1

Key Performance Statistics:

Investment securities: 8

Average coupon

5.14 %

5.27 %

5.19 %

5.20 %

5.14 %

Average asset yield

4.87 %

4.95 %

4.87 %

4.83 %

4.89 %

Average asset yield, excluding "catch-up" premium amortization

4.89 %

4.93 %

4.90 %

4.91 %

4.83 %

Average coupon - as of period end

5.05 %

5.25 %

5.19 %

5.17 %

5.14 %

Average asset yield - as of period end

4.91 %

4.93 %

4.93 %

4.94 %

4.92 %

Average actual CPR for securities held during the period

13.0 %

13.2 %

9.7 %

8.3 %

8.7 %

Average forecasted CPR - as of period end

8.6 %

10.3 %

9.6 %

8.6 %

7.8 %

Total premium amortization benefit (cost)

$                         (47)

$                         (52)

$                         (51)

$                         (57)

$                         (30)

TBA securities:

Average coupon - as of period end 20

4.89 %

4.11 %

4.98 %

5.11 %

5.22 %

Average implied asset yield 9

4.87 %

5.42 %

4.91 %

5.31 %

5.14 %

Combined investment and TBA securities - average asset yield, excluding "catch-up" premium
amortization 11

4.89 %

4.98 %

4.91 %

4.95 %

4.87 %

Cost of funds: 13

Repurchase agreements - average funding cost

3.74 %

3.79 %

4.13 %

4.43 %

4.44 %

TBA securities - average implied funding cost 10

3.46 %

3.45 %

4.03 %

4.31 %

4.29 %

Interest rate swaps - average periodic income 12

(0.81) %

(0.83) %

(1.01) %

(1.25) %

(1.56) %

Average total cost of funds, inclusive of TBAs and interest rate swap periodic income, net 11

2.89 %

2.92 %

3.10 %

3.17 %

2.86 %

Repurchase agreements - average funding cost as of period end

3.75 %

3.77 %

3.98 %

4.38 %

4.49 %

Interest rate swaps - average net pay/(receive) rate as of period end 21

(0.92) %

(1.01) %

(1.29) %

(1.76) %

(2.34) %

Net interest spread:

Combined investment and TBA securities average net interest spread, excluding "catch-up" premium
amortization

2.00 %

2.06 %

1.81 %

1.78 %

2.01 %

Expenses % of average stockholders' equity - annualized

0.96 %

1.10 %

1.39 %

1.12 %

1.11 %

Economic return (loss) on tangible common equity - unannualized 22

6.7 %

(1.6) %

11.6 %

10.6 %

(1.0) %

Key Interest Rate Hedge Statistics

Interest rate swaps:

Average interest rate swaps, notional amount (excluding forward starting swaps), net

$                    75,216

$                    71,607

$                    59,863

$                    45,656

$                    45,849

Average pay-fixed rate

2.71 %

2.65 %

2.56 %

2.25 %

1.94 %

Average receive-floating rate

3.65 %

3.67 %

3.98 %

4.35 %

4.38 %

U.S. Treasury securities:

Average short U.S. Treasury securities, at cost

$                    16,939

$                    16,772

$                    18,414

$                    21,466

$                    19,754

Average short U.S. Treasury securities yield

4.23 %

4.25 %

4.18 %

4.21 %

4.16 %

Average long U.S. Treasury securities, at cost

$                    12,370

$                    12,033

$                    12,964

$                      4,749

$                      2,044

Average long U.S. Treasury securities yield

3.70 %

3.71 %

3.74 %

4.01 %

4.45 %

U.S. Treasury futures:

Average short U.S. Treasury futures, at cost

$                      4,006

$                      3,210

$                      1,901

$                      1,834

$                      1,208

Average short U.S. Treasury futures implied yield 23

4.73 %

4.64 %

4.71 %

4.60 %

4.53 %

Average long U.S. Treasury futures, at cost

$                      9,917

$                    11,147

$                         708

$                           —

$                           —

Average long U.S. Treasury futures implied yield 23

3.89 %

3.71 %

3.92 %

— %

— %

Average reverse repurchase agreement rate

3.63 %

3.68 %

4.00 %

4.34 %

4.33 %

*Except as noted below, average numbers for each period are weighted based on days on the Company's books and records. All percentages are annualized, unless otherwise noted.
Numbers in financial tables may not total due to rounding.

Tangible net book value per common share excludes preferred stock liquidation preference and goodwill. Table includes non-GAAP financial measures and/or amounts derived from non-GAAP measures. Refer to "Use of Non-GAAP Financial Information" for additional discussion of non-GAAP financial measures. "Catch-up" premium amortization cost/benefit is reported in interest income on the accompanying consolidated statements of operations. Amount reported in gain (loss) on derivatives instruments and other securities, net in the accompanying consolidated statements of operations. Dollar roll income represents the price differential, or "price drop," between the TBA price for current month settlement versus the TBA price for forward month settlement. Amount includes dollar roll income (loss) on long and short TBA securities. Amount excludes TBA mark-to-market adjustments. Represents periodic interest rate swap settlements. Amount excludes interest rate swap termination fees, mark-to-market adjustments and price alignment interest income (expense) on margin deposits. Other interest income (expense), net includes interest income on cash and cash equivalents, price alignment interest income (expense) on margin deposits, and other miscellaneous interest income (expense). Investment securities include Agency MBS, CRT and non-Agency securities. Amounts exclude TBA and forward settling securities accounted for as derivative instruments in the accompanying consolidated balance sheets and statements of operations. The average implied asset yield and associated gross income for TBA dollar roll transactions is extrapolated by adding the average TBA implied funding cost (Note 10) to the net dollar roll yield. The net dollar roll yield is calculated by dividing dollar roll income (Note 5) by the average net TBA balance (cost basis) outstanding for the period. The implied funding cost/benefit of TBA dollar roll transactions is determined using the "price drop" (Note 5) and market-based assumptions regarding the "cheapest-to-deliver" collateral that can be delivered to satisfy the TBA contract, such as the anticipated collateral's weighted average coupon, weighted average maturity and projected 1-month CPR. The average implied funding cost/benefit for TBA transactions represents the Company's long TBA position only, weighted based on the Company's daily average long TBA position outstanding for the period. Amount calculated on a weighted average basis based on average balances outstanding during the period and their respective asset yield/funding cost. Represents interest rate swap periodic cost/income measured as a percent of total mortgage funding (Investment Securities Repo, other debt and net TBA securities (at cost)). Cost of funds excludes U.S. Treasury, option-based, and other supplemental hedges used to hedge a portion of the Company's interest rate risk and U.S. Treasury Repo. Non-Agency MBS, at fair value, excludes $70 million, $69 million, $70 million, $69 million and $66 million of other mortgage credit investments held as of June 30 and March 31, 2026 and December 31, September 30 and June 30, 2025, respectively. Includes TBA dollar roll position and, if applicable, forward settling securities accounted for as derivative instruments in the accompanying consolidated balance sheets and statements of operations. Amount is net of short TBA securities. Average repurchase agreements and other debt excludes U.S. Treasury Repo. Average stockholders' equity calculated as the average month-ended stockholders' equity during the quarter. Average tangible net book value "at risk" leverage during the period was calculated by dividing the sum of the daily weighted average Investment Securities Repo, other debt, and TBA and forward settling securities (at cost) outstanding for the period by the sum of average stockholders' equity adjusted to exclude goodwill. Leverage excludes U.S. Treasury Repo. Tangible net book value "at risk" leverage as of period end was calculated by dividing the sum of the amount outstanding under Investment Securities Repo, other debt, net TBA position and forward settling securities (at cost), and net receivable / payable for unsettled investment securities outstanding by the sum of total stockholders' equity adjusted to exclude goodwill. Leverage excludes U.S. Treasury Repo. Average TBA coupon is for the long TBA position only. Includes forward starting swaps not yet in effect as of reported period-end. Economic return (loss) on tangible common equity represents the sum of the change in tangible net book value per common share and dividends declared on common stock during the period over the beginning tangible net book value per common share. The implied yields for Treasury futures are calculated based on the "cheapest-to-deliver" security that can be delivered to satisfy the futures contract identified at the time the futures contract was initiated using data sourced from a third-party model. STOCKHOLDER CALL
AGNC invites stockholders, prospective stockholders and analysts to attend the AGNC stockholder call on July 21, 2026 at 8:30 am ET. Interested persons who do not plan on asking a question and have internet access are encouraged to utilize the webcast at www.AGNC.com. Those who plan on participating in the Q&A or do not have internet available may access the call by dialing (877) 300-5922 (U.S. domestic) or (412) 902-6621 (international). Please advise the operator you are dialing in for the AGNC Investment Corp. stockholder call.

A slide presentation will accompany the call and will be available in the Investors section of the Company's website at www.AGNC.com. Select the Q2 2026 Stockholder Presentation link to download the presentation in advance of the stockholder call.

An archived audio of the stockholder call combined with the slide presentation will be available on the AGNC website after the call on July 21, 2026. In addition, there will be a phone recording available one hour after the call on July 21, 2026 through August 4, 2026. Those who are interested in hearing the recording of the presentation, can access it by dialing (855) 669-9658 (U.S. domestic) or (412) 317-0088 (international), passcode 8844707.

For further information, please contact Investor Relations at (301) 968-9300 or [email protected].

ABOUT AGNC INVESTMENT CORP.
Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading investor in Agency residential mortgage-backed securities (Agency MBS), which benefit from a guarantee against credit losses by Fannie Mae, Freddie Mac, or Ginnie Mae. We invest on a leveraged basis, financing our Agency MBS assets primarily through repurchase agreements, and utilize dynamic risk management strategies intended to protect the value of our portfolio from interest rate and other market risks.

AGNC has a track record of providing favorable long-term returns for our stockholders through substantial monthly dividend income, with over $16 billion of common stock dividends paid since inception. Our business is a significant source of private capital for the U.S. residential housing market, and our team has extensive experience managing mortgage assets across market cycles.

We use our website (www.AGNC.com) and AGNC's LinkedIn and X accounts to distribute information about the Company. Investors should monitor these channels in addition to our press releases, filings with the U.S. Securities and Exchange Commission ("SEC"), public conference calls and webcasts, as information posted through them may be deemed material. Our website, alerts and social media channels are not incorporated by reference into, and are not a part of, this document or any report filed with the SEC. To learn more about The Premier Agency Residential Mortgage REIT, please visit www.AGNC.com, follow us on LinkedIn and X, and sign up for Investor Alerts.

FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements are based on estimates, projections, beliefs and assumptions of management of the Company at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements or from our historic performance due to a variety of important factors, including, without limitation, changes in monetary policy and other factors that affect interest rates, MBS spreads to benchmark interest rates, the forward yield curve, or prepayment rates; the availability and terms of financing; changes in the market value of the Company's assets; general economic or geopolitical conditions; liquidity and other conditions in Agency MBS and other financial markets; and legislative and regulatory changes that could adversely affect the business of the Company. Certain factors that could cause actual results to differ materially from those contained in the forward-looking statements are included in the Company's periodic reports filed with the Securities and Exchange Commission ("SEC"). Copies are available on the SEC's website, www.sec.gov. The Company disclaims any obligation to update or revise any forward-looking statements based on the occurrence of future events, the receipt of new information, or otherwise.

USE OF NON-GAAP FINANCIAL INFORMATION
In addition to the results presented in accordance with GAAP, the Company's results of operations discussed in this release include certain non-GAAP financial information, including "net spread and dollar roll income"; "economic interest income" and "economic interest expense"; and the related per common share measures and certain financial metrics derived from such non-GAAP information, such as "cost of funds" and "net interest spread."

Net spread and dollar roll income available to common stockholders is measured as comprehensive income (loss) available (attributable) to common stockholders (GAAP measure) adjusted to: (i) exclude gains/losses on investment securities recognized through net income or other comprehensive income and gains/losses on derivative instruments and other securities (GAAP measures), (ii) exclude retrospective "catch-up" adjustments to premium amortization cost due to changes in projected CPR estimates and (iii) include interest rate swap periodic income/ cost, TBA dollar roll income and other miscellaneous interest income/expense. As defined, net spread and dollar roll income available to common stockholders represents net interest income/ expense (GAAP measure) adjusted to exclude retrospective "catch-up" adjustments to premium amortization cost due to changes in projected CPR estimates and to include TBA dollar roll income, interest rate swap periodic income/cost and other miscellaneous interest income/expense, less total operating expense (GAAP measure) and dividends on preferred stock (GAAP measure).

By providing users of the Company's financial information with such measures in addition to the related GAAP measures, the Company believes users have greater transparency into the information used by the Company's management in its financial and operational decision-making. The Company also believes that it is important for users of its financial information to consider information related to the Company's current financial performance without the effects of certain transactions that are not necessarily indicative of its current investment portfolio performance and operations.

Specifically, the Company believes the inclusion of TBA dollar roll income in its non-GAAP measures is meaningful as TBAs are economically equivalent to holding and financing generic Agency MBS using short-term repurchase agreements but are recognized under GAAP in gain/ loss on derivative instruments in the Company's statement of operations. Similarly, the Company believes that the inclusion of periodic interest rate swap settlements in such measures, which are recognized under GAAP in gain/loss on derivative instruments, is meaningful as interest rate swaps are the primary instrument the Company uses to economically hedge against fluctuations in the Company's borrowing costs and inclusion of periodic interest rate swap settlements is more indicative of the Company's total cost of funds than interest expense alone. Finally, the Company believes the exclusion of "catch-up" adjustments to premium amortization cost is meaningful as it excludes the cumulative effect from prior reporting periods due to current changes in future prepayment expectations and, therefore, exclusion of such "catch-up" cost or benefit is more indicative of the current earnings potential of the Company's investment portfolio.

However, because such measures are incomplete measures of the Company's financial performance and involve differences from results computed in accordance with GAAP, they should be considered as supplementary to, and not as a substitute for, results computed in accordance with GAAP. In addition, because not all companies use identical calculations, the Company's presentation of such non-GAAP measures may not be comparable to other similarly-titled measures of other companies.

A reconciliation of GAAP comprehensive income (loss) to non-GAAP "net spread and dollar roll income" is included in this release.

CONTACT:
Investors - (301) 968-9300
Media - (301) 968-9303

SOURCE AGNC Investment Corp.

Boston, Massachusetts--(Newsfile Corp. - July 20, 2026) - Block & Leviton is investigating Pentair (NYSE: PNR) for potential securities law violations. Investors who have lost money in their Pentair investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/pnr.

What is this all about?

Block & Leviton is investigating whether Pentair plc and certain of its executives violated federal securities laws in connection with what the company told investors about the health of inventory in its Pool channel. On April 28, 2026, Pentair guided to roughly 1% second-quarter sales growth and 2-4% full-year growth, and management told investors it had evaluated a range of Pool revenue scenarios and reflected the expected sell-in pressure in that guidance. Then, after the market closed on July 14, 2026, Pentair pre-announced that preliminary second-quarter sales would be approximately $930 million — down about 17% year-over-year — and slashed its full-year outlook, attributing the shortfall to Pool channel inventory destocking that was "more pronounced" than previously estimated and that it estimated would cut full-year Pool sales by roughly $250 million. The company also disclosed that its chief financial officer had departed on July 10, 2026, just days before the warning, with the former CFO returning on an interim basis. Pentair shares fell sharply on the news.

Who is eligible?

Anyone who purchased Pentair common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (888) 256-2510.

Whistleblower?

If you have non-public information about Pentair, you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [email protected] or by phone at (888) 256-2510.

Why should you contact Block & Leviton?

Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, call (888) 256-2510 or email [email protected] with any questions.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (888) 256-2510
Email: [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305801

Source: Block & Leviton LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, has reported that Seismic, the global leader in sales enablement, scaled AI-assisted outbound prospecting across its go-to-market team on ZoomInfo, and in its own user surveys attributed 39% of active pipeline to opportunities identified or influenced by signals from ZoomInfo, according to the company. Seismic runs a well-developed outbound model, where business development representatives and outside sal.

VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, has reported that Tegus, an investment-research platform that investors rely on to inform their decisions, cut its conversation-intelligence spending by 50% compared with its previous vendor after consolidating that work onto ZoomInfo, according to the company. Tegus redirected the savings into sales incentives and went on to exceed its targets for the next 2 quarters. Tegus combines expert insights, comp.

July 20, 2026 16:05 ET  | Source: Workhorse Group, Inc.

DETROIT, July 20, 2026 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse” or the “Company”), a North American OEM and provider of all-electric trucks, step vans, shuttles and buses, today announced that on July 20, 2026, the Human Resource Management and Compensation Committee of the Company’s Board of Directors (the “Committee”) granted 93,750 restricted stock units (“RSUs”) to Jody Davis under the Company’s Inducement Equity Award Plan (the “Inducement Plan”) in connection with Mr. Davis’s hiring and appointment as Chief Financial Officer. The award was granted as an inducement material to Mr. Davis entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).  

The RSUs will vest over a three-year period, in three equal installments on the first, second and third anniversaries of June 1, 2026, subject to Mr. Davis’s continued employment with the Company through the applicable vesting dates.

About Workhorse Group Inc.

Headquartered in the Detroit area with a commercial-scale manufacturing plant in Union City, Indiana, Workhorse (Nasdaq: WKHS) is redefining what a medium-duty truck should be. Workhorse builds software-first, electric trucks, shuttles and buses that are powerful, cost-efficient, reliable, safe and comfortable — all with zero tailpipe emissions. Our deep experience building electric vehicles at scale drives intentional innovations designed to help customers lower operating costs, improve fleet performance, enhance the driver experience, and maximize uptime without compromise. More information is available at www.workhorse.com.

Media Relations Contacts:

Workhorse
John Williams, Communications
+1-206-660-5503, [email protected]

ICR, Inc.
[email protected]

Investor Relations Contact:
[email protected]

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that are not historical facts, including those regarding the Company's achievement of its priorities and its other plans, objectives, expectations, business strategies, future operations, financial performance, prospects, and other future events or developments, are forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, and estimates as of the date of this press release and are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties are described in greater detail under the caption "Risk Factors" in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by applicable law.

ToplineMark Zuckerberg became the world’s fifth-richest person on Monday, reclaiming the rank from Michael Dell as shares in his hardware firm declined, extending a cooling period for the stock since climbing to an all-time high last month.

The hardware firm’s stock has cooled since skyrocketing to an all-time high last month.

Copyright 2026 The Associated Press. All rights reserved

Key FactsShares of Dell dropped 3.3% as of Monday afternoon, adding to an 8.8% slide the previous week and a more than 18% decline since hitting an intraday all-time record high of $469 on June 1.

Dell, who holds about 265.7 million Dell shares, saw his net worth cut by $2 billion to $221.1 billion, ranking him directly below Zuckerberg ($222.1 billion) on Forbes’ list of the world’s wealthiest people.

Meta’s stock, which traded down as much as 1.6%, rose to roughly break even on the day shortly before market close.

big number200%. That’s how much Dell shares have swelled by this year as they more than tripled in value, despite a recent selloff. Michael Dell’s fortune opened 2026 at $141 billion, ranking him as the 13th-richest person in the world, and his wealth has surged 864% since hitting $22.9 billion in 2020.

what to watch forDell will report Q2 earnings next month, while Meta reports next week.

key backgroundDell has become one of the largest beneficiaries of the broader buildup of AI infrastructure, as the hardware firm has become a key supplier to data centers. The company reported an 88% surge in revenue through its previous quarter, boosting Dell’s stock by 39% in its best trading session ever. AI server revenue skyrocketed by 757% over the previous year, Dell reported, with expectations for annual sales topping $60 billion. President Donald Trump, who became a shareholder in the first quarter, has urged investors to buy Dell, urging traders to “go out and buy a Dell.”

further readingForbesMichael Dell’s Net Worth Surges Up $35 Billion From Dell’s Best Day Ever—Passing Zuckerberg As 6th RichestBy Ty Roush

, /PRNewswire/ -- Ross Stores, Inc. (Nasdaq: ROST) announced the grand opening of 47 new stores nationwide during June and July, including 35 Ross Dress for Less® ("Ross") and 12 dd's DISCOUNTS® locations across 15 states and territories. With these new openings, the Company is on track to open approximately 110 stores this year.

"Each new opening allows us to deliver compelling value to even more customers while creating new jobs and making a positive impact in the local communities," said Richard Lietz, Executive Vice President, Property Development. "Building on the strong new store performance in 2025 and the Spring openings this year, we are excited to grow Ross Dress for Less' store base in Puerto Rico, New York, and Michigan while also continuing to deepen our presence in key Sunbelt states. For dd's, we are also pleased to expand within our existing markets in California, Florida, North Carolina, and Texas."

In connection with these openings, Ross Stores continued its longstanding tradition of community engagement by making donations to local Boys & Girls Clubs or First Book literacy partners, supporting youth development and access to educational resources in the neighborhoods it serves.

"Looking ahead, we see attractive opportunities as off‑price continues to grow, and we are well positioned to capitalize on them," said Mr. Leitz.

For more information on these new openings, please visit Ross Dress for Less Grand Openings and dd's DISCOUNTS Grand Openings.

About Ross Stores, Inc.
Ross Stores, Inc. is an S&P 500, Fortune 500, and Nasdaq 100 (ROST) company headquartered in Dublin, California, with fiscal 2025 revenues of $22.8 billion. Currently, the Company operates Ross Dress for Less® ("Ross"), the largest off-price apparel and home fashion chain in the United States with 1,952 locations in 44 states, the District of Columbia, Guam, and Puerto Rico. Ross offers first-quality, in-season, brand name and designer apparel, accessories, footwear, and home fashions for the entire family at savings of 20% to 60% off department and specialty store regular prices every day. The Company also operates 376 dd's DISCOUNTS® stores in 23 states that feature a more moderately-priced assortment of first-quality, in-season apparel, accessories, footwear, and home fashions for the entire family at savings of 20% to 70% off moderate department and discount store regular prices every day. Additional information is available at www.rossstores.com.

Contact:

Connie Kao

Senior Vice President, Investor & Media Relations

(925) 965-4668

[email protected]

SOURCE Ross Stores, Inc.

July 20, 2026 16:30 ET  | Source: Fossil Group, Inc.

RICHARDSON, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) (the “Company”) today announced that its 2026 Annual Meeting of Stockholders will be held on October 2, 2026 at 9:00 a.m. Central Time (the “2026 Annual Meeting”). The Company’s Board of Directors has set August 3, 2026 as the record date for the 2026 Annual Meeting. The location of the 2026 Annual Meeting will be specified in the Company’s proxy statement for the 2026 Annual Meeting.

Pursuant to the Company’s Sixth Amended and Restated Bylaws (the “Bylaws”), the Company is providing its stockholders with the deadlines for stockholder proposals and director nominations for the 2026 Annual Meeting. The deadlines for submitting stockholder proposals and director nominations pursuant to the Bylaws, as set forth in the Company’s proxy statement for the 2025 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission on November 21, 2025, no longer apply.

Stockholders submitting proposals or director nominations under the Bylaws must provide written notice to the Company’s Secretary at its principal executive offices at 901 S. Central Expressway, Richardson, Texas 75080, no later than the close of business on July 30, 2026, which is the 10th day after the date of the Company’s public announcement of the date of the 2026 Annual Meeting and which the Company has determined, for purposes of Rule 14a‑8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to be a reasonable time before it begins to print and mail its proxy materials. In addition, stockholders must otherwise comply with the applicable provisions of the Bylaws and the Exchange Act.

Additional information regarding the 2026 Annual Meeting will be provided in the Company’s proxy statement and related materials.

About Fossil Group, Inc.

Fossil Group, Inc. is a global design, marketing, distribution and innovation company specializing in lifestyle accessories. Under a diverse portfolio of owned and licensed brands, our offerings include watches, jewelry, handbags, small leather goods, belts and sunglasses. We are committed to delivering the best in design and innovation across our owned brands, Fossil, Michele, Relic, Skagen and Zodiac, and licensed brands, Armani Exchange, Diesel, Emporio Armani, Michael Kors, Skechers and Tory Burch. We bring each brand story to life through an extensive distribution network across numerous geographies, categories, and channels. Certain press release and SEC filing information concerning the Company is also available at www.fossilgroup.com.    

Investor Relations:

Christine Greany
The Blueshirt Group
[email protected]

Chipotle Mexican Grill shares are sliding. Why is CMG stock falling? Cyclospora Outbreak Dents Fast-Casual Foot Traffic Across the SectorA foodborne Cyclospora parasite outbreak linked to contaminated iceberg lettuce sourced from Mexico has rattled the fast-casual dining space, sending foot traffic lower across multiple chains. The FDA traced the outbreak to lettuce used in Taco Bell’s supply chain, prompting supplier Taylor Farms and distributor Sysco to pull the product.

Placer.ai foot traffic data through July 17 shows Taco Bell visits fell 18.9% compared to its day-of-week average from January through early July. Chipotle was not spared, recording a 6.9% decline in customer visits over the same window, as broader consumer anxiety around fresh ingredients at Mexican-style fast-casual restaurants appears to be weighing on traffic regardless of direct supply chain involvement.

Earnings Preview Adds Another Layer of CautionBeyond the sector noise, traders appear to be trimming exposure ahead of Chipotle’s upcoming earnings release. Analysts are currently projecting earnings of 32 cents per share on revenue of $3.33 billion.

The stock has a history of sharp moves in either direction around quarterly results and with the report approaching some investors are choosing to reduce risk rather than carry a full position into the print. Any sign that recent foot traffic softness has fed through into weaker comparable sales figures could amplify the downside reaction when results hit.

CMG Versus The Tape: A Breakdown Test, Not A BreakoutThe chart is not helping CMG. The stock sits 2.5% below its 20‑day SMA $33.86 and 1% below its 100‑day SMA $33.33, levels that often act like speed bumps when buyers try to spark a rebound. It is still holding 1.4% above its 50‑day SMA $32.56 but remains 6.3% below its 200‑day SMA $35.24, which keeps the longer‑term trend tilted bearish.

Momentum is not signaling capitulation. RSI is at 47.20, a neutral zone that shows the move is not washed out but also not showing the kind of upside pressure that forces shorts to cover and sidelined buyers to chase. That neutrality matters because it suggests the stock can keep chopping or leaking without the technical relief valve of an oversold snapback.

Zoom out and the backdrop stays heavy. CMG is down 37.04% over the past 12 months. June delivered an oversold RSI event and the 52‑week low. July produced a swing high and a break above resistance. This pullback now serves as a test of whether that breakout reflected real demand or simply a temporary repricing in a thin summer tape.

Key levels are taking center stage. Resistance sits at $33.50, a nearby pivot zone that overlaps the 100‑day area where rebounds often stall. Support is $30.50, a floor that becomes more important if selling continues, sitting above the $28.04 52‑week low zone. If bulls cannot reclaim the moving‑average cluster, the next question becomes how quickly price starts probing that lower shelf.

CMG Shares Are DroppingCMG Price Action: Chipotle shares were down 4.07% at $33.04 at the time of publication on Monday, according to Benzinga Pro.

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

A space economy boom is turning into a stock market collapse. After the monster Space Exploration Technologies (better known as SpaceX) IPO earlier this year, space stocks began to slip, and quickly, from their highs. Rocket Lab (RKLB 2.66%) could be called the poster child for these wild gyrations in space stocks.

The maker of rockets and other space systems saw its stock rise by more than 150% at one point over the last 12 months before falling 55% from a high set in May. As of this writing, the stock trades at $67.50. Should you buy shares of Rocket Lab below $70?

The answer is clear if you look at the numbers.

Image source: Getty Images.

A potentially transformative acquisition Rocket Lab has defied the odds. It looks as if the business is poised to become the second vertically integrated spaceflight player, operating alongside SpaceX as a transportation and services juggernaut for companies wanting to operate in orbit.

It has a new rocket, the Neutron, which is undergoing testing and will bring it to payload parity with SpaceX's current workhorse, the Falcon 9. In addition to sending payloads into orbit, Rocket Lab has developed and acquired space systems products, including satellite production, space capsules, energy generation, and communications.

Combined, this aggressive push to vertically integrate space economy services has led to $680 million in trailing 12-month revenue, up over 1,000% in the last five years. Now, it is making a potentially transformative acquisition of Iridium, a satellite communications provider. This is being done to accelerate its timeline to directly compete with SpaceX's Starlink satellite internet service and to obtain L-band spectrum rights at a reasonable price. Iridium is being acquired for $8 billion and generates $871 million in revenue, more than Rocket Lab's entire business today.

If this acquisition closes and the Neutron rocket begins commercial flights, Rocket Lab's capabilities will start looking more like SpaceX's in the near future.

With a falling share price, you might think that Rocket Lab now trades at a reasonable price relative to its growth potential. However, as with many space economy stocks, shares of Rocket Lab seem to have gotten well ahead of themselves in the last few years.

Today's Change

(

-2.66

%) $

-1.80

Current Price

$

65.82

After this drawdown, Rocket Lab trades at a price-to-sales ratio (P/S) of 55, which is an extreme multiple rarely seen in the stock market. Even if revenue grows more than 10 times over the next five years, it will only bring this P/S ratio down to around the S&P 500's average, before considering shareholder dilution.

For this reason, investors should not buy Rocket Lab stock right now. Wait for it to fall even more from here.

, /PRNewswire/ -- Zions Bancorporation, N.A. (NASDAQ: ZION) ("Zions" or "the Bank") today reported net earnings applicable to common shareholders of $452 million, or $3.05 per diluted common share, for the second quarter of 2026. This compares with net earnings of $243 million, or $1.63 per diluted common share, in the second quarter of 2025, and $232 million, or $1.56 per diluted common share, in the first quarter of 2026.

Harris H. Simmons, Chairman and CEO of Zions Bancorporation, commented, "We're very pleased with the quarterly results, as earnings per share, excluding net equity investment gains, increased 10% to $1.74, compared to $1.58 in the same period a year ago. Net equity investment gains of $215 million on Visa Class B-1 shares and $37 million on SBIC investments added $1.12 and $0.19 per share, respectively, compared to net equity investment gains of $9 million, or $0.05 per share a year ago."

Mr. Simmons continued, "We're particularly pleased with the organic growth in customer-related noninterest income, which increased 11% over last year's period, with particularly strong growth from capital markets activities, and solid growth in a variety of other categories. While loan growth compared to last year's quarter was modest at 3%, annualized linked-quarter growth was strong at 8%. Deposits grew 4% from last year and were seasonally lower compared to the first quarter."

Mr. Simmons concluded, "We're also encouraged by strong growth in tangible book value per share, which increased 22% to $44.74 from $36.81, while our Common Equity Tier 1 capital ratio further strengthened to 11.8% from 11.0% a year ago. At the same time, we're proud of our ongoing solid credit results, with annualized net charge-offs of 0.06%."

For the complete second quarter 2026 earnings release, including detailed financial schedules, please visit www.zionsbancorporation.com.

Supplemental Presentation and Conference Call

Zions has posted a supplemental presentation to its website in advance of its discussion of second quarter financial results, scheduled for 5:30 p.m. ET on July 20, 2026. Media representatives, analysts, investors, and the general public are invited to participate by calling (877) 709-8150 (domestic and international) and entering the meeting number 13761560, or by joining the on-demand webcast. A link to the webcast will be available on the Company's website at www.zionsbancorporation.com. Following the event, the webcast will be archived and accessible for 30 days.

About Zions Bancorporation, N.A.

Zions Bancorporation, N.A. is one of the nation's premier financial services companies with annual net revenue of $3.4 billion in 2025, and total assets of approximately $89 billion at December 31, 2025. The Bank operates principally through seven separately managed, geographically defined bank divisions, each operating under its own local brand and management, and serving customers primarily in 11 Western states: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming.

Zions is a consistent recipient of national and state-level customer survey awards recognizing excellence in small- and middle-market banking. It is also a leader in public finance advisory services and Small Business Administration lending. Zions is included in both the S&P MidCap 400 and NASDAQ Financial 100 indices. Additional investor information, along with links to local banking brands, is available at www.zionsbancorporation.com.

Forward-Looking Information

The earnings release contains "forward-looking statements" as defined under the Private Securities Litigation Reform Act of 1995. These statements reflect management's current expectations and assumptions regarding future events and outcomes. However, they are inherently subject to known and unknown risks, uncertainties, and other factors that could cause actual results, performances, achievements, industry developments, or regulatory outcomes to differ materially from those expressed or implied. Forward-looking statements may include, among others:

Statements concerning the beliefs, plans, objectives, goals, targets, commitments, designs, guidelines, expectations, anticipations, and future financial condition, operating results, and performance of Zions Bancorporation, National Association, and its subsidiaries (collectively "Zions Bancorporation, N.A.," "the Bank," "we," "our," "us"); and Statements preceded or followed by, or that include, terminology such as "may," "might," "can," "continue," "could," "should," "would," "believe," "anticipate," "estimate," "forecast," "expect," "intend," "target," "commit," "design," "plan," "project," "will," or similar words and expressions, including their negative forms. Forward-looking statements are not guarantees and should not be relied upon as representing management's views as of any subsequent date. Actual results and outcomes may differ materially from those expressed or implied. Factors that could cause such differences include, but are not limited to:

The quality and composition of our loan and investment securities portfolios and the quality and composition of our deposits; Changes in general industry, political, and economic conditions, including increases in the national debt, elevated or persistent inflation, economic slowdowns or recessions, and other macroeconomic challenges; changes in interest rates or reference rates, which could negatively impact our revenues and expenses, the valuation and performance of our assets and liabilities, and the availability and cost of capital and liquidity; Political developments, including government shutdowns and other significant disruptions and changes in the funding, size, scope, and effectiveness of the government and its agencies and services; The effects of newly enacted and proposed regulations affecting us and the banking industry, as well as changes and uncertainties in the interpretation, enforcement, and applicability of laws and fiscal, monetary, regulatory, trade, and tax policies; Actions taken by governments, agencies, central banks, and similar organizations, including those that result in decreases in revenue, increases in regulatory bank fees, insurance assessments, and capital standards; and other regulatory requirements; Evolving trade policies and disputes, such as proposed and implemented tariffs and resulting market volatility and uncertainty, including the effects on supply chains, expenses, and revenues for both us and our customers; Judicial, regulatory, and administrative inquiries, investigations, examinations or proceedings and the outcomes thereof that create uncertainty for, or are adverse to, us or the banking industry; Changes in our credit ratings; The growing presence of credit unions, financial technology companies ("fintechs"), and other emerging competitors within the financial services industry, including in the markets in which we operate; Our ability to innovate and address competitive pressures and other factors that may affect aspects of our business, such as pricing, the relevance of and demand for our products and services, and our ability to recruit and retain talent; The potential for both positive and disruptive impacts of emerging technologies, including stablecoins and other digital currencies, tokenized deposits, blockchain, artificial intelligence ("AI"), quantum computing, and related innovations affecting both us and the banking industry; Our ability to complete projects and initiatives and execute our strategic plans, manage our risks, control compensation and other expenses, and achieve our business objectives; Our ability to develop and maintain technology and information security systems, along with effective controls designed to guard against fraud, cybersecurity, and privacy risks and related incidents, particularly given the accelerating pace at which threat actors are developing and deploying increasingly sophisticated and targeted tactics against the financial services industry; The occurrence of fraud, theft, or other forms of misconduct perpetrated by external parties, including customers and business partners, or by our own employees; Our ability to provide adequate oversight of our suppliers to help us prevent or mitigate effects upon us and our customers of inadequate performance, systems failures, or cyber and other incidents by, or affecting, third parties upon whom we rely for the delivery of various products and services; The effects of wars, geopolitical conflicts, and other local, national, or international disasters, crises, or conflicts that may occur in the future; Natural disasters, pandemics, wildfires, catastrophic events, and other emergencies and incidents, and their impact on our operations, our customers' business, and the communities we serve, including the increasing difficulty and expense of obtaining property, auto, business, and other insurance products; Diverging and evolving policy, legal, regulatory, and political developments—combined with differing stakeholder perspectives related to governance, environmental, and social matters—may subject us to potentially conflicting requirements and expectations; Securities and capital markets behavior, including volatility and changes in market liquidity and our ability to raise capital; The possibility that our recorded goodwill could become impaired, which may have an adverse impact on our earnings and shareholders' equity; The impact of bank closures or adverse developments at other banks on general investor sentiment regarding the stability and liquidity of banks; Adverse news and other expressions of negative public opinion—whether directed at us, other financial institutions, the banking industry, or the broader market—that may adversely affect our reputation and the industry more broadly; and Other assumptions, risks, or uncertainties described in this earnings release, and in our filings with the SEC. We caution against placing undue reliance on forward-looking statements, as they reflect our views only as of the date they are issued. Except as required by law, we expressly disclaim any obligation to update any factors or publicly announce revisions to forward-looking statements to reflect future events or developments.

SOURCE Zions Bancorporation

GREENWICH, Conn.--(BUSINESS WIRE)--W. R. Berkley Corporation (NYSE: WRB) today reported its second quarter 2026 results. Summary Financial Data (Amounts in thousands, except per share data)   Second Quarter   Six Months   2026   2025   2026   2025                 Gross premiums written $ 4,144,000   $ 3,977,769   $ 7,929,766   $ 7,661,708 Net premiums written 3,430,234   3,351,439   6,604,580   6,484,742                 Net income to common stockholders 452,261   401,288   967,478   818,860 Net.

Barclays upgrades Lumentum stock to Overweight on Monday following a months-long selloff.

TULSA, OK / ACCESS Newswire / July 20, 2026 / BOK Financial Corporation (NASDAQ:BOKF) today reported operating results for the second quarter ended June 30, 2026. The earnings release can be viewed here: https://investor.bokf.com/Q2-2026-Earnings-Full-Release-PDF.

BOK Financial Corporation will host a conference call to review second quarter 2026 financial results at noon central time on Tuesday, July 21, 2026. To access the event by telephone, please dial 1.800.715.9871 toll free, or 1.646.307.1963, conference ID: 6617678.

For those unable to join the live presentation, a webcast replay will be available shortly after the live call's conclusion on the company's investor relations website or by dialing 1.800.770.2030 and referencing replay PIN 6617678. A replay of the webcast will also be available for 90 days on the company's investor relations website: https://investor.bokf.com/corporate-profile/default.aspx.

About BOK Financial Corporation

BOK Financial Corporation is a $53 billion regional financial services company headquartered in Tulsa, Oklahoma with $129 billion in assets under management or administration. The company's stock is publicly traded on NASDAQ under the Global Select market listings (BOKF). BOK Financial Corporation's holdings include BOKF, NA; BOK Financial Securities, Inc.; and BOK Financial Private Wealth, Inc. BOKF, NA's holdings include TransFund and Cavanal Hill Investment Management, Inc. BOKF, NA operates banking divisions across eight states as: Bank of Albuquerque; Bank of Oklahoma; Bank of Texas; and BOK Financial in Arizona, Arkansas, Colorado, Kansas and Missouri; as well as having limited purpose offices in Connecticut, Nebraska, Tennessee, and Wisconsin. Through its subsidiaries, BOK Financial Corporation provides commercial and consumer banking, brokerage trading, investment and trust services, mortgage origination and servicing, and an electronic funds transfer network. For more information, visit www.bokf.com.

Contact:

Heather King
Director of Investor Relations
214.676.4666

SOURCE: BOK Financial

VettaFi’s Midyear Market Outlook symposium Thursday saw industry leaders take on the big questions. Where is the market going? How should investors and advisors navigate uncertainty and potential volatility? Leaders from Fidelity Investments and Invesco both joined for one of the early segments, focused on innovative U.S. strategies.

Key Takeaways: Fidelity Investments and Invesco leaders joined VettaFi’s Midyear Outlook symposium to discuss what the rest of the year holds. Fidelity’s Treacy and Invesco’s Schroeder discussed the continued geopolitical and concentration risk as issues to watch. Both provided some examples of funds that could help address just that. The segment, hosted by VettaFi Head of Research Todd Rosenbluth, included thoughts from Fidelity Investments Institutional Portfolio Manager Benjamin Treacy, CFA, and Invesco Director, Factor and QQQ Equity Product Strategy Paul Schroeder. The duo spoke to Rosenbluth about a myriad of topics looming over the second half.

Prompted by Rosenbluth, both spoke to what caught their eye to start the year. For Treacy, the resilience of markets despite geopolitical and inflationary headwinds stood out. The rise of small-caps despite those headwinds, too, piqued his interest.

“The rise in small-caps versus large-caps, we haven’t seen that in quite a while, but over the last year, small-caps have been quite strong,” Treacy said. “We’ve seen an improvement in the earnings picture there, which I think has helped drive some of that outperformance versus large.”

Schroeder, meanwhile, spoke to the VIX as a measure of the volatility from those headwinds. While markets have done well, he said, the underlying risk tension has stood out to him.

“So even though we’ve seen strong index performance at the top, there’s been a lot of churning and shifts in leadership underneath that have really provided for a lot of exciting conversations,” Schroeder said.

See more: This Elevated International ETF Looks Compelling Right Now Both firm leaders pointed to small- and mid-cap stocks picking up steam. Treacy emphasized the growth in conversations on that space of late than 12 months prior. Schroeder, meanwhile, grounded that interest amid a contrast between the Magnificent Seven — down almost 5% on the year — and the overall U.S. market. Measured by the S&P 500, for example, the market is up 8%, he said. That tipped Schroeder to underscore his firm’s equal weight fund.

Treacy, meanwhile, spoke to Fidelity Investments’ fundamental suite of ETFs. That suite, which has grown with new international offerings in recent years, offers actively managed ETFs “that look to beat our benchmarks by actively selecting securities,” he said. Treacy spoke to funds like the Fidelity Fundamental Large Cap Core ETF (FFLC).

“They are multi-manager ETFs,” he said. “So each one of these is being managed and we’re selecting stocks based on the insights and conviction levels that we get from our fundamental portfolio managers here at Fidelity.”

He spoke to, for another example, the Fidelity Investments Fundamental Small-Mid ETF (FFSM). FFSM charges a 43 basis point (bps) fee to offer exposure to that space that Treacy highlighted.

“It’s not just small, it’s not just mid, it’s small and mid,” he said. “So it allows us to buy companies…across a very wide swath of the market, right?”

“This portfolio leverages the insights of 12 different portfolio managers at Fidelity that run small- and mid-cap portfolios,” he added. “We have an expert in midcap growth stocks, so we leverage their conviction as well as mid-cap value and small-cap growth and small-cap value.”

See more: How Active Investing Can Get More From Growth Stocks This Year The Fidelity Fundamental Large Cap Growth ETF (FFLG), meanwhile, also offers an active approach. That helps the fund diverge from the benchmark where needed — helping adapt to changes with, for example, the Magnificent Seven.

“So take the Mag Seven… We have actually been  little bit underweight the Mag Seven as a group, , but that’s not to say we don’t own any of them,” he said. “We pick and choose and we own where we think we have the strongest conviction… And we think the fundamentals are the strongest in the portfolio.”

FFLG charges 38 bps and has returned 29.6% over the last 12 months. FFSM, meanwhile, has returned 39.9% in the same time.

Looking ahead, both firm leaders made the case for strategies that can add a bit more differentiation. By leaning on fundamentals, those strategies can help portfolios handle those churning risks under the hood.

“I think as an active manager, so forgive me for being a little bit biased, but we are very much believers in the strength of active management,” Treacy said. “I think just what the indexes are doing or have done isn’t the whole story. And to be able to have disciplined active management approaches in these areas like we do, I think is important to think about.”

For more news, information, and strategy, visit the ETF Investing Content Hub.

Fidelity Investments® is an independent company unaffiliated with VettaFi LLC (“VettaFi”). These articles do not form any kind of legal partnership, agency affiliation, or similar relationship between VettaFi and Fidelity Investments, nor is such a relationship created or implied by the articles herein. VettaFi LLC is the author and owner of these articles.

1272481.1.0

The Zacks Medical – Products industry is navigating an uneven operating environment where macroeconomic headwinds are colliding with strong structural healthcare demand. Rising tariffs, persistent inflation in electronic components, freight and raw materials, as well as supply-chain normalization challenges are pressuring margins and forcing manufacturers to rely on pricing actions, productivity initiatives and supply-chain diversification. Operational disruptions, product remediation efforts and elevated R&D spending are also weighing on near-term profitability.

Despite these challenges, underlying demand remains resilient, supported by healthy procedural volumes, hospital capital spending, aging demographics and growing prevalence of chronic diseases. At the same time, rapid innovation across AI-enabled diagnostics, robotic-assisted surgery, cardiovascular interventions and digital care platforms is creating new growth opportunities and expanding addressable markets.

These contrasting forces suggest that while the industry's near-term outlook remains constrained by cost pressures, companies with differentiated technologies, innovation pipelines and disciplined execution are best positioned to outperform.

Terumo (TRUMY - Free Report) , QuidelOrtho (QDEL - Free Report) , Lumexa Imaging Holdings, Inc. (LMRI - Free Report) and  Brainsway (BWAY - Free Report) are countering industry pressures through pricing actions, cost-control initiatives, differentiated innovation pipelines, and focused execution across their core growth franchises and rising demand for advanced diagnostic solutions.

Industry Description The industry includes companies that provide medical products and cutting-edge technologies for healthcare services, including Abbott Laboratories, Stryker and Boston Scientific. These companies are primarily focused on research and development and cater to vital therapeutic areas like cardiovascular, nephrology and urology devices.

The increase in procedure volumes is driving sales, particularly for surgical products and services. At the same time, cost-cutting measures are helping companies improve their bottom-line performance.

However, the industry’s profitability picture is under significant strain. War-related disruptions are likely to cut into margins and may force companies into another complex and costly supply-chain restructuring.

Major Trends Shaping the Future of the Medical Products Industry Innovation Continues to Create New Growth Engines: The industry's strongest growth driver remains continuous product innovation. Companies are accelerating investments in AI-powered imaging, robotic-assisted surgery, electrophysiology, structural heart therapies, diabetes care and digital health platforms to capture expanding clinical opportunities. Per the FDA list, there are currently more than 1,500 FDA-cleared AI/ML-enabled devices, and the figure is likely to increase as several medical device makers are actively developing such devices for efficient and faster diagnosis and treatment. Remote patient monitoring platforms are projected to reach $30.9 billion by 2026-end and $110.7 billion by 2033, per a Grand View research report.

New product launches, broader regulatory approvals and increasing physician adoption are helping companies penetrate higher-growth therapeutic categories while improving procedural efficiency and patient outcomes. Robust innovation pipelines are also supporting pricing power and strengthening long-term competitive positioning across the medical products landscape.

Migration to Ambulatory and Home-Based Care: The U.S. market is experiencing a sustained shift from inpatient hospital settings to ASCs and home-based monitoring. The ASC market is set to reach $205 billion by 2030, per a Grand View Research report, driven by procedure cost efficiency, CMS policy changes and expanded device portfolios tailored for outpatient use. Coupled with increased adoption of wearables and connected devices, care decentralization is reshaping technology requirements, pricing structures and competitive dynamics for device makers.

Accelerating Innovation in Robotics and Specialty Therapeutics: Surgical robotics and specialty cardiovascular interventions are driving the next wave of value creation, with robotics poised to witness a 10.5% CAGR, per a Grand View Research report, and pulsed-field ablation transforming electrophysiology standards.

Intuitive Surgical’s platform evolution, entry of versatile competitors and expansion of structural heart solutions (TMVR, PFA) highlight a winner-take-all dynamic. Innovation, clinical outcome evidence and ecosystem lock-in are creating durable advantages in profitability and return on invested capital (ROIC), while commoditized hardware businesses remain under pressure.

Procedure Recovery and Hospital Spending Support Demand: Healthy procedure volumes, favorable demographic trends and resilient hospital capital spending continue to support industry growth. Aging populations, the rising prevalence of chronic diseases and the growing adoption of minimally invasive procedures are driving sustained demand across the cardiovascular, orthopedic, neuromodulation and diagnostic markets. Hospitals also continue to invest in advanced imaging systems, robotics and workflow automation to improve productivity and patient care, providing manufacturers with strong recurring demand despite broader macroeconomic uncertainty.

Tariffs and Cost Inflation Continue to Pressure Margins: The industry's biggest challenge remains rising input costs stemming from tariffs, inflation and supply-chain pressures. Higher prices for semiconductors, metals, freight and other critical components are squeezing margins, while some companies continue to navigate operational disruptions and remediation costs. Although manufacturers are offsetting part of the pressure through pricing actions, productivity initiatives and supply-chain optimization, elevated costs are likely to remain a key headwind for earnings growth in the near term.

Zacks Industry Rank The Zacks Medical Products industry falls within the broader Zacks Medical sector.

It currently carries a Zacks Industry Rank #169, which places it in the bottom 32% of more than 245 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all member stocks, indicates dull near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Before we present a few medical product stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry Performance The industry has underperformed its own sector as well as the Zacks S&P 500 composite over the past year.

Stocks in this industry have collectively declined 26.1% against the Zacks Medical sector’s rise of 12.7%. The S&P 500 has increased 21.1% in the same time frame.

One-Year Price Performance

Industry's Current Valuation On the basis of the forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 16.3X compared with the S&P 500’s 20.7X and the sector’s 21.1X.

Over the past five years, the industry has traded as high as 27.4X and as low as 15.3X, with the median being 21.8X, as the charts show.

Price-to-Earnings Forward Twelve Months (F12M)

Price-to-Earnings Forward Twelve Months (F12M)

4 Potential Winning Medical Product Stocks BrainsWay continues to emerge as one of the industry's fastest-growing niche medtech companies, driven by expanding adoption of its Deep TMS platform. Strong system placements, a growing installed base, recurring multi-year contracts and improving reimbursement coverage are supporting sustained revenue visibility.

Additional catalysts include expanding clinical indications, the SWIFT protocol, strategic investments in mental health networks and Neurolief, and a large untapped market opportunity for non-invasive neuromodulation therapies. Still, continued investment in commercialization, reimbursement expansion and broader physician adoption remain necessary, while geopolitical and supply-chain uncertainties could modestly affect execution.

For 2026, BrainsWay has guided revenues of $66-$68 million (27-30% growth), operating margin of 13-14% and adjusted EBITDA of $12-$14 million, indicating strong bottom-line expansion.

For this Israel-based company, the Zacks Consensus Estimate for fiscal 2026 revenues is pegged at $68.5 million, projecting 31.2% growth. The consensus mark for EPS is pinned at 33 cents per share, implying an 8.3% decline year over year. The company delivered a trailing four-quarter average earnings surprise of 72.23%.

Presently, the company sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Price and Consensus: BWAY

Terumo appears well positioned for a strong second half of 2026, supported by broad-based growth across its Cardiac & Vascular, Neuro, Blood & Cell Technologies and Pharmaceutical Solutions businesses. Continued demand in North America, pricing actions, expanding neurovascular adoption, growth in CDMO and PLAJEX businesses, and the first full-year contribution from Terumo Organ Technologies should sustain high-single-digit revenue growth while profit expands faster than sales. The absence of large one-time restructuring charges also strengthens earnings visibility.

However, U.S. tariffs, higher raw material costs and geopolitical uncertainty remain key risks, although management expects pricing and cost-control initiatives to offset much of the pressure.

The company expects revenues and operating profit to grow 8% and 20%, respectively, in 2026. For this Japanese company, the Zacks Consensus Estimate for 2026 revenues of $7.69 billion indicates year-over-year growth of 2.4%. The consensus estimate for earnings of 70 cents per share indicates an improvement of 14.8%. Presently, the company carries a Zacks Rank #2 (Buy).

Price and Consensus: TRUMY

Despite a difficult first quarter, QuidelOrtho's long-term outlook is improving as its growth increasingly shifts beyond seasonal respiratory testing. The LEX Diagnostics acquisition strengthens its point-of-care molecular diagnostics portfolio, while the U.S. launch of the high-sensitivity troponin assay and international rollout of the VITROS 450 platform should support higher laboratory revenues in the second half.

Management also expects margin expansion through restructuring, procurement savings and facility consolidation. Nevertheless, a weak respiratory season, China IVD pricing reforms and geopolitical disruptions affecting Middle East orders could continue to pressure near-term growth and profitability.

For this San Dieogo, CA-based company, the Zacks Consensus Estimate for 2026 revenues is pegged at $2.68 billion, suggesting a decline of 1.8%. The consensus mark for earnings per share (EPS) is pinned at $1.87, indicating a decline of 11.8%. However, revenues and earnings are likely to improve 2.7% and 25.7%, respectively, in 2027. The company delivered a trailing four-quarter average negative earnings surprise of 15.66%. Presently, the company carries a Zacks Rank of 2.

Price and Consensus: QDEL

Lumexa's growth prospects remain supported by structural shifts toward outpatient imaging and rising demand for advanced diagnostic modalities. Robust PET and MRI growth, accelerating de novo center openings, tuck-in acquisitions, expanding joint ventures with health systems and increasing adoption of AI-enabled imaging solutions provide multiple growth levers for the second half of 2026.

Favorable industry trends, including aging demographics, preventive screening and site-of-care migration, further strengthen the outlook. However, weather-related volume disruptions, seasonal payer mix changes and cybersecurity-related compliance costs could create intermittent operational headwinds despite management's strong execution.

For this Raleigh, NC-based company, the Zacks Consensus Estimate for 2026 revenues is pegged at $1.07 billion, projecting 298% growth. The consensus mark for EPS is pinned at 77 cents, implying a 302.6% improvement year over year. The company delivered a trailing four-quarter average negative earnings surprise of 685%. Presently, it carries a Zacks Rank #2.

Price and Consensus: LMRI

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hub Group To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Hub Group between April 28, 2023 and May 11, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 20, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hub Group, Inc. ("Hub Group" or the "Company") (NASDAQ: HUBG) and reminds investors of the August 28, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Hub Group's financial statements prepared for the periods from Q1 2023 to Q4 2024, including annual reports for 2023 and 2024, contained material misstatements caused by the premature and incorrect recognition of certain transactions concerning, among other things, Hub Group's operating revenue, operating income, revenue recognition, effectiveness of internal controls and procedures, and drivers of financial results and growth; and (2) Hub Group's financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements caused by the understatement of purchased transportation costs and accounts payable concerning, among other things, Hub Group's operating expenses, purchased transportation and warehousing expenses, operating income, effectiveness of internal disclosure controls and procedures, and drivers of financial results and growth.

On February 5, 2026, Hub Group announced that the Company's financial statements for the first three quarters of 2025 should not be relied upon and would be restated due to "an error that resulted in the understatement of purchased transportation costs and accounts payable in the first nine months of 2025." The Company revealed that its reports for those quarters "were in each case materially misstated due to the aforementioned error and should no longer be relied upon" and that "the Company [wa]s also continuing to assess the effectiveness of its disclosure controls and procedures and internal control over financial reporting and appropriate remediation steps." The Company also estimated that "[t]he total amount of the reduction to accounts payable and purchased transportation costs related to this issue that was recorded during these periods is $77 million."

This news caused the price of Hub Group stock to decline roughly 18%, from $51.33 per share at close on February 5, 2026, to $41.96 per share at close on February 6, 2026.

On May 12, 2026, Hub Group announced that it had "identified certain transactions that were prematurely or incorrectly recognized or not adequately supported," causing its 2023 and 2024 annual reports filed with the SEC to be "materially misstated," such that they "should no longer be relied upon." The Company did not quantify the expected misstatement, although it "expect[ed] to conclude that it did not maintain effective disclosure controls and procedures and internal control over financial reporting for each of the years ended December 31, 2024 and 2023."

This news caused the price of Hub Group stock to decline a further 13%, from $41.86 per share at close on May 11, 2026, to $36.62 per share at close on May 12, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Hub Group's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Hub Group class action, go to www.faruqilaw.com/HUBG or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Hub Group Securities Class Action Lawsuit:

What is the Hub Group securities fraud lawsuit about?

The lawsuit alleges Hub Group made misleading statements about revenue recognition, transportation costs, accounts payable, internal controls, and financial reporting, causing multiple financial statements to contain material accounting misstatements.

Who may be eligible to participate in the lawsuit?

Investors who purchased or acquired Hub Group (NASDAQ: HUBG) securities between April 28, 2023 and May 11, 2026 may be eligible to participate if they suffered losses related to the alleged misconduct.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff represents the proposed class and helps oversee the litigation. Eligible investors must file a motion with the court by August 28, 2026. Investors can share in any recovery without serving as lead plaintiff.

What should investors do if they purchased Hub Group stock during the Class Period?

Investors should review their trading records, preserve relevant documents, and evaluate their legal rights. Those who suffered losses may wish to consult counsel regarding participation in the lawsuit or seeking lead plaintiff status before the deadline.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for clients. The firm can evaluate your potential claims and explain your legal options at no upfront cost.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305826

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), of the important August 31, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Insulet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Insulet class action, go to https://rosenlegal.com/cases/insulet-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 31, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Insulet’s manufacturing controls and procedures were defective; (2) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Insulet class action, go to https://rosenlegal.com/cases/insulet-corporation/join   or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

The reporters had worked on stories about security concerns involving a jet gifted to the U.S. by the Qatari government that was being used as Air Force One.

20.7.2026 22:15

Zámořské trhy v poslední čtvrtině obchodního dne reflektovaly eskalační vyjádření prezidenta Trumpa i Íránských představitelů a z mírně kladných čísel briskně přetočily do záporu. Nevydržela tak dobrá nálada z úvodu seance a široký index S&P 500 klesá potřetí v řadě.

Index Dow Jones -0,59 % na 51839,26 b.
S&P 500 -0,19 % na 7443,28 b.
Nasdaq Composite -0,05 % na 25508,07 b.

Index S&P 500 -0,19 % na 7443,28 b. Nejsilnější sektory S&P Změna Nejslabší sektory S&P Změna Komunikační služby +0,7 % Zdravotní péče -1,2 % Energie +0,5 % Základní materiály -0,9 % Informační technologie +0,1 % Průmysl -0,8 % Nejsilnější akcie S&P Změna Nejslabší akcie S&P Změna Global Payments (GPN) +5,9 % Carvana (CVNA) -4,8 % Lumentum Holdings (LITE) +4,5 % Honeywell Aerospace (HONA) -4,3 % Teradyne (TER) +3,5 % Oracle Corp (ORCL) -4,0 % Axon Enterprise (AXON) +3,4 % KKR (KKR) -3,9 % Marvell Technology (MRVL) +3,3 % United Parcel Service (UPS) -3,9 %
Martin Varecha
Fio banka, a.s.
Prohlášení

July 20, 2026 16:15 ET  | Source: FinWise Bank

MURRAY, Utah, July 20, 2026 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced that the Company has acquired the technology platform and related assets of Tallied Technologies, Inc. ("Tallied"), the credit card issuance and processing platform that has powered the Bank's co-branded credit card programs. With this acquisition, FinWise now owns its card technology stack end-to-end, from application, through issuing, processing and servicing.

Transaction Highlights

Expanded revenue capture. FinWise now retains the fees, interchange and interest economics on programs running on the Tallied platform that were previously shared with a third-party program manager.Reduced integration risk. The technology is already integrated into the Bank's systems, with live programs running on it today. Cardholders and program partners should experience no interruption in service.Minimal capital outlay. The transaction was funded with cash on hand and is not expected to have a material impact on the Company's capital ratios. The Bank remains well capitalized.Proven team joins FinWise. Tallied's engineering and operations team has joined FinWise, preserving full continuity of platform knowledge and accelerating the Company's product roadmap.Disciplined, bounded near-term investment. FinWise expects integration and transition costs of approximately $4.0 million in total over the next year. The Company expects the costs to be greater in the next two quarters and to narrow over the following two quarters as it fully integrates the platform into the bank and eliminates duplicative third-party vendor and platform costs. A Proprietary, Modern Card Operating System

The Tallied platform is a fully cloud-native, SOC2 certified and API-first operating system for modern credit cards. It spans application and decisioning engines, card issuance-processing, a rewards engine, AI-powered fraud scoring, dispute handling and compliance self-audit capabilities. Built by a seasoned issuer-processing team and developed with substantial investment from leading fintech investors, the platform now becomes a proprietary asset of the Company.

A Uniquely Positioned Buyer

As the issuing bank for the programs operating on the Tallied platform — with the technology already integrated into the Bank's systems and live programs running on it — FinWise had first-hand knowledge of the platform's architecture, performance, programs and underlying receivables. That visibility enabled the Company to move quickly once Tallied had begun a sales process, structure the transaction terms, and substantially reduce the integration and execution risk that typically accompanies technology acquisitions. FinWise's acquisition thesis is centered on owning the platform technology and capabilities. The Bank plans to separately evaluate the optimal long-term approach to the associated credit card receivables, as described under "Financial Impact and Outlook" below.

"This acquisition is the logical next step in the technology roadmap we have been executing for several years. We worked closely with this platform over the last twelve months and when it became available, the strategic decision was to purchase it. We structured this transaction with the capital discipline our shareholders expect: a modest and clearly bounded near-term investment in exchange for a proprietary technology asset we believe will compound in value across our fintech lending, payments, and card businesses," said Jim Noone, CEO of FinWise Bancorp.

"We built FintechConnect and its easily integrated APIs to support our lending sponsorship. We built MoneyRails™ to own our payments infrastructure. We expanded into BIN Sponsorship to enable card offerings to the fintech and embedded finance markets we serve,” Mr. Noone continued. “Each of those investments was modest at the outset and became core to how FinWise grows. Owning the credit card operating system provides the core component for the credit card tech stack and the flexibility that comes with this. FinWise can now offer our partners speed to market, real-time controls and regulatory-grade compliance on a single platform while capturing economics that were previously shared with third parties."

Financial Impact and Outlook

Integration and transition costs. FinWise expects integration and transition costs of approximately $4.0 million in total over the next year. The Company expects the costs to be greater in the next two quarters and to narrow over the following two quarters as it fully integrates the platform into the bank and eliminates duplicative third-party vendor and platform costs. These estimates exclude amortization of acquired intangible assets — primarily the platform and customer relationships — a non-cash item for which valuations and useful lives are being finalized. The Company expects to complete initial purchase accounting by the end of the third quarter of 2026 and will provide an update at that time.

Credit card receivables. Because Tallied will no longer serve as a third-party program manager, approximately $50 million of credit card balances that previously carried credit enhancement will convert to standard credit card balances held on the Bank's balance sheet, with the Bank retaining the full economics — including interest income and interchange — as well as the associated credit exposure. These are seasoned receivables originated under the Bank's underwriting standards that the Bank has held and monitored since origination. Consistent with its disciplined approach to balance sheet management, the Bank is evaluating whether to retain these receivables over the long term in order to pursue the path it believes optimizes risk-adjusted returns for shareholders.

Business outlook. As a result of the transaction, the Company’s prior guidance of approximately $217 million in credit-enhanced balances by the end of 2026 no longer applies, reflecting the change in how those balances are structured. We will continue to provide updates on credit-enhanced balances on a quarterly basis going forward.

FinWise Bancorp Second Quarter 2026 Earnings Conference Call and Webcast

FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), the parent company of FinWise Bank, will report its second quarter 2026 results and host a conference call and webcast after the market close on Wednesday, July 29, 2026. The conference call will be held at 5:00 p.m. ET on Wednesday, July 29, 2026, to discuss financial results for the second quarter of 2026. The dial-in number is 1-877-423-9813 (toll-free) or 1-201-689-8573 (international). The conference ID is 13760730. Please dial the number 10 minutes prior to the scheduled start time.

The webcast will be available on the Company’s website at FinWise Earnings Call Live Webcast and a replay of the call will be available at Investor Relations | FinWise Bancorp (gcs-web.com) for six months following the call.

In addition to questions asked live by analysts during the call, the Company will also accept for consideration questions submitted via email prior to 5:00 p.m. ET on Wednesday, July 29, 2026. Please email questions to [email protected].

"Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995

This release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our strategies, goals, beliefs, expectations, estimates, intentions, capital raising efforts, financial condition and results of operations, future performance and business. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “believe,” “expect,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “project,” “projection,” “forecast,” “budget,” “goal,” “target,” “would,” “aim” and “outlook,” or similar expressions generally indicate a forward-looking statement.

These forward-looking statements are based on management assumptions and involve risks and uncertainties that are subject to change based on various important factors, some of which are beyond our control. Numerous competitive, economic, regulatory, legal and technological events and factors, among others, could cause our actual results or performance to differ materially from those indicated in these forward-looking statements, including but not limited to the market price of our common stock prevailing from time to time, the nature of other investment opportunities presented to us from time to time and our cash flows from operations and our ability to integrate the Tallied platform successfully. If one or more events related to these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may differ materially from our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. All forward-looking statements and information set forth herein are based on management’s current beliefs and assumptions as of the date hereof and speak only as of the date they are made. For a more complete discussion of the assumptions, risks and uncertainties related to our business, you are encouraged to review our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the fiscal year ended December 31, 2025. We do not undertake to update any forward-looking statement whether written or oral, that may be made from time to time by us or by or on behalf of us, except as may be required under applicable law.

About FinWise

FinWise provides Banking and Payments solutions to fintech brands. Its existing Strategic Program Lending business, conducted through scalable API-driven infrastructure, powers deposit, lending and payments programs for leading fintech brands.

As part of Strategic Program Lending, FinWise also provides a Credit Enhanced Balance Sheet Program, which addresses the challenges that lending and card programs face diversifying their funding sources and managing capital efficiency. In addition, FinWise manages other Lending programs such as SBA 7(a), Owner Occupied Commercial Real Estate, and Leasing, which provide flexibility for disciplined balance sheet growth. The Company is also expanding and diversifying its business model by incorporating Payments (MoneyRails™) and BIN Sponsorship offerings. Through its compliance oversight and risk management-first culture, the Company is well positioned to guide fintechs through a rigorous process to facilitate regulatory compliance.

https://www.finwise.bank/

Contacts
[email protected]
[email protected]

Fifth Third Bancorp (FITB) is upgraded to 'Buy' following the successful Comerica acquisition and robust Q2'26 earnings beat. FITB's net interest income surged 48% year-over-year, driven by Comerica integration and strong commercial & industrial loan growth. The Comerica merger positions FITB as the ninth-largest U.S. bank, with significant run-rate cost synergies and book value expansion potential.

NOVI, Mich., July 20, 2026 (GLOBE NEWSWIRE) -- Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies, announced today it received FDA 510(k) clearance for its patented ThermAffyx™ Patient Safety System. This Class II medical device combines active patient warming, securement and pressure reduction in a single platform designed for the more than 3 million robotic-assisted surgical procedures performed annually worldwide. Product trials at healthcare facilities are scheduled to begin in August, with revenue generation expected to commence in Q3 2026.

Historically, surgical teams have pieced together separate solutions to address warming and securement issues. ThermAffyx simplifies that process by combining two critical patient safety functions into a single system that fits naturally into existing surgical workflows.

Traditional underbody securement pads help prevent patient movement but do not provide active warming. This is especially problematic in robotic procedures and surgeries that require the patient to be tilted in Trendelenburg position. Studies have found that only 17% to 21% of a patient's body surface area may be available for forced-air warming during these procedures, and more than one-quarter of robotic surgery patients are hypothermic in recovery, despite warming interventions.

The ThermAffyx Patient Safety System was developed to address this gap by integrating active underbody warming directly into an anti-slip securement pad. The radiolucent heating element is powered by Gentherm's proprietary Carbotex® carbon-fiber heating technology. This is more than a new warming device. It's a purpose-built patient safety platform designed around the realities of modern robotic surgery. 

The FDA clearance follows Gentherm's 510(k) submission announced earlier this year and represents a significant expansion of the company's patient temperature management portfolio.

About Gentherm
Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2025, the company recorded annual sales of approximately $1.5 billion and secured $2.2 billion in automotive new business awards. For more information, go to www.gentherm.com. 

Investor Contact 
Gregory Blanchette
[email protected]
248.308.1702

Media Contacts
Haley Baur
[email protected]
248.289.9711

I have high conviction in real assets right now. I detail why I believe that quality real asset investments will be worth materially more over time. I also share two of my highest conviction real asset investments of the moment.

Key Takeaways PulteGroup's Q2 EPS is estimated to be $2.38, down 21.5%, with revenues projected to fall 9.6%.Higher sequential closings and community growth may support PulteGroup despite affordability pressures.PulteGroup's gross margin is expected to be 24.2% as incentives, discounts and pricing pressure weigh. PulteGroup Inc. (PHM - Free Report) is scheduled to report its second-quarter 2026 results on July 22, before the opening bell.

In the last reported quarter, the company’s adjusted earnings per share (EPS) missed the Zacks Consensus Estimate by 0.6%, and revenues surpassed the same by 0.7%. On a year-over-year basis, adjusted EPS declined 30.4%, and revenues decreased 12.4% year over year.

PulteGroup’s earnings topped the consensus mark in three of the trailing four quarters and missed on one occasion, with an average surprise of 2.6%.

Trend in PHM Stock’s Estimate RevisionThe Zacks Consensus Estimate for PHM’s second-quarter EPS has increased to $2.38 from $2.36 over the past 30 days. The estimated figure indicates a 21.5% decrease from the year-ago EPS of $3.03.

The consensus mark for total revenues is pegged at $3.98 billion, implying a 9.6% year-over-year decline.

Factors Likely to Have Shaped PulteGroup’s Q2 EarningsTopline: PulteGroup’s second-quarter revenues are likely to have been supported by higher expected closing volumes. Management guided for 6,700-7,100 home closings during the quarter, reflecting a sequential increase from the first quarter as homes already under construction progressed toward delivery. Continued growth in community count, projected at 3-5% year over year, and the company's sizable land pipeline are likely to have supported sales activity.

For the second quarter, our model predicts home closings to decline 8.6% year over year to 6,982 units. Segment-wise, for the second quarter, our model predicts overall Homebuilding revenues (which contributed 97.9% to total revenues in the first quarter of 2026) to decrease 10.2% year over year to $3.87 billion. Our model expects Financial Services revenues (which contributed 2.1% to total revenues in the first quarter) to grow 0.4% year over year to $101.5 million.

Demand trends were expected to remain relatively resilient despite elevated mortgage rates. The company continued to benefit from healthy demand among move-up and active-adult buyers, particularly in Florida, the Northeast and parts of the Southeast, while its strategic shift toward a higher build-to-order mix likely enhanced order quality and future revenue visibility. Management also noted that buyer traffic remained healthy and seasonal demand trends held up well despite macroeconomic and geopolitical uncertainty.

However, affordability constraints likely continued to weigh on first-time buyers, limiting broader demand. Elevated incentives remained necessary to stimulate sales in a competitive housing market, while average selling prices (ASPs) were guided to a range of $540,000-$550,000, suggesting continued pricing pressure. Regional weakness in parts of Texas and the West, together with cautious consumer sentiment tied to mortgage rates, may also have constrained top-line growth. Our model predicts the ASP of homes closed to decrease 2.1% year over year to $547,200.

Margins: Margins are expected to have remained under pressure during the quarter. Management projected home sale gross margin of 24.1-24.4%, indicating that the second quarter is likely to represent the low point of the year. Elevated incentives, competitive pricing and the closing of previously sold spec homes carrying heavier discounts are expected to have weighed on profitability.

Our model predicts homebuilding gross margin to be 24.2% for the quarter, down from the year-ago period level of 27%. We predict SG&A expenses (as a percentage of home sales revenues) to be 9.2%, up 10 basis points year over year.

Nevertheless, lower construction costs, supported by reduced lumber prices and procurement savings across several building materials, likely provided some relief. Continued efforts to reduce finished spec inventory and disciplined production management are likely to have supported operational efficiency. Share repurchases, which reduced the average diluted share count, were expected to have provided a modest boost to EPS even as lower financial services profitability and softer pricing weighed on the bottom line.

Orders & Backlogs: Our model expects PulteGroup’s net new orders to be up 1.4% year over year to 7,180 units in the second quarter. We expect the total backlog to decline 1.4% to 10,625 units, with the total backlog value dropping 2.4% year over year to $6.68 billion.

What Our Model Unveils for PHMOur proven model does not conclusively predict an earnings beat for PulteGroup this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.

PHM’s Earnings ESP: The company has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

Zacks Rank of PHM: The stock currently carries a Zacks Rank #3.

You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks to ConsiderHere are other companies in the Zacks Construction sector, which, according to our model, have the right combination of elements to post an earnings beat.

Boise Cascade Company (BCC - Free Report) has an Earnings ESP of +6.50% and a Zacks Rank of 1 at present.

Boise Cascade’s earnings beat estimates in two of the last four quarters, missed on one occasion and met on the remaining occasion, the average surprise being 40.8%. The company’s earnings for the second quarter of 2026 are expected to decline 25% year over year.

Dycom Industries, Inc. (DY - Free Report) currently has an Earnings ESP of +0.47% and a Zacks Rank of 1.

Dycom’s earnings beat estimates in all the last four quarters, the average surprise being 25%. The company’s earnings for the second quarter of fiscal 2027 are expected to increase 39.3% year over year.

CRH plc (CRH - Free Report) has an Earnings ESP of +4.08% and a Zacks Rank of 3.

CRH’s earnings beat estimates in two of the last four quarters, missed on one occasion and met on the remaining occasion, the average surprise being 0.7%. The company’s earnings for the second quarter of 2026 are expected to inch up 1% year over year.